China Universal Asset Management Co., Ltd. Collegium Pharmaceutical, Inc Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 6,196 shares of COLL stock, worth $203,910. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,196
Previous 3,844
61.19%
Holding current value
$203,910
Previous $123,000
94.31%
% of portfolio
0.03%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding COLL
# of Institutions
254Shares Held
36.9MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$191 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$86.7 Million1.79% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$85.2 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$77.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$54.5 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.12B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...